Rosuvastatin calcium and Nasal polyps - a phase IV clinical study of FDA data

Summary:

Nasal polyps is reported as a side effect among people who take Rosuvastatin calcium (rosuvastatin calcium), especially for people who are female, 60+ old, also take Dupixent, and have Asthma.

The phase IV clinical study analyzes which people have Nasal polyps when taking Rosuvastatin calcium. It is created by eHealthMe based on reports of 24,757 people who have side effects when taking Rosuvastatin calcium from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,356 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Nasal polyps?

Nasal polyps (masses that develop in the lining of the nose) is found to be associated with 388 drugs and 376 conditions by eHealthMe. Check the latest studies of Nasal polyps.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

24,757 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 15 people (0.06%) have Nasal polyps.

Could Rosuvastatin calcium cause Nasal polyps?

Among these 15 people:

What is the gender of people who have Nasal polyps when taking Rosuvastatin calcium? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Nasal polyps when taking Rosuvastatin calcium? *

What are other drugs people take besides Rosuvastatin calcium? *

What are other side effects people have besides Nasal polyps? *

Dyspnea (difficult or laboured breathing): 12 people, 80.00%
Asthma: 11 people, 73.33%
Sinusitis (inflammation of sinus): 7 people, 46.67%
Pneumonia: 7 people, 46.67%
Headache (pain in head): 7 people, 46.67%
Cough: 7 people, 46.67%
Lung Disorder (lung disease): 6 people, 40.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 6 people, 40.00%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 5 people, 33.33%
High Blood Pressure: 5 people, 33.33%

What are the existing conditions these people have? *

Asthma: 7 people, 46.67%
Sinusitis (inflammation of sinus): 2 people, 13.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 13.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 6.67%
Immunodeficiency Common Variable: 1 person, 6.67%
Hiv Infection: 1 person, 6.67%
Drowsiness: 1 person, 6.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Nasal polyps?

- Check whether Nasal polyps is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosuvastatin calcium:

Rosuvastatin calcium (25,356 reports)

Nasal polyps treatments and more:

Nasal polyps (19,447 reports)

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasal polyps:

Nasal polyps (388 drugs)

Browse all the conditions that are associated with Nasal polyps:

Nasal polyps (376 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.